Tian Zeng
Hunan Province Key Laboratory Of Tumor Cellular & Molecular Pathology
Hengyang, China
Hengyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
ENO1 lactylation drives bevacizumab resistance through metabolic reprogramming and angiogenesis in ovarian cancer.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: January 03, 2026
Mechanisms and Opportunities of the Arrestin Beta Signaling Pathway in Liver Diseases.
Journal: DNA and cell biology
Published: October 22, 2025
BdNOX5 mediates gut microbiota homeostasis via ROS regulation in Bactrocera dorsalis.
Journal: Pest management science
Published: October 10, 2025
ESM1 and protein lysine L-lactylation modification (Pan-kla) in ovarian cancer: coexpression, clinical significance, and prognostic value.
Journal: Diagnostic pathology
Published: October 01, 2025
PD1 cell membrane-coated Ru(ll)-Pt(lV) complex nanoparticles inhibit liver metastatic melanoma via cascade immune activation.
Journal: Journal of nanobiotechnology
Published: September 12, 2025
Lactic Acid Drives ESM1 to Attenuate DNA Damage and CD8+ T Cell Infiltration in Cancer.
Journal: Oncology research
Published: August 06, 2025
Identification and mechanism analysis of biomarkers related to butyrate metabolism in COVID-19 patients.
Journal: Annals of medicine
Published: March 12, 2025
BCAA metabolism: the Achilles' heel of ovarian cancer, polycystic ovary syndrome, and premature ovarian failure.
Journal: Frontiers in endocrinology
Published: February 21, 2025
ESM1 suppresses LncRNA GAS5/miR-23a-3p/PTEN axis to promote the cisplatin-chemotherapy resistance of ovarian cancer cells via activating the PI3K/AKT pathway.
Journal: Discover oncology
Published: December 01, 2024
Utilization of DNA Replication factor MCM2 by Cancer.
Journal: Current cancer drug targets
Published: September 06, 2024
Last Updated: 09/26/2026